Bone marrow adipose tissue: A new player in cancer metastasis to bone

Frontiers in Endocrinology

Volumn 7, Issue JUL, 2016, Pages

  Morris, Emma V ^a   Edwards, Claire M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Bone metastasis; Cancer induced bone disease; Marrow adipose tissue; Multiple myeloma; Prostate cancer

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; OSTEOPROTEGERIN;

ADIPOGENESIS; BONE DEVELOPMENT; BONE MARROW; BONE METASTASIS; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; HEMATOLOGIC MALIGNANCY; HUMAN; MULTIPLE MYELOMA; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROSTATE CANCER; SHORT SURVEY; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WHITE ADIPOCYTE;

EID: 84983063584     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2016.00090     Document Type: Short Survey

References (70)

1. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 3(6):453-8. doi:10.1038/nrc1098
2. Paget S. The distribution of secondary growths in cancer of the breast 1889. Cancer Metastasis Rev (1989) 8(2):98-101.
3. Ewing J. Neoplastic Diseases. A Treatise on Tumours. 3rd ed. Philadelphia: W.B. Saunders Co. Ltd (1928).
4. Sheth KR, Clary BM. Management of hepatic metastases from colorectal cancer. Clin Colon Rectal Surg (2005) 18(3):215-23. doi:10.1055/s-2005-916282
5. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer (2002) 2(8):563-72. doi:10.1038/nrc865
6. Kuchuk I, Hutton B, Moretto P, Ng T, Addison CL, Clemons M. Incidence, consequences and treatment of bone metastases in breast cancer patients-experience from a single cancer centre. J Bone Oncol (2013) 2(4):137-44. doi:10.1016/j.jbo.2013.09.001
7. Coleman RE. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev (2001) 27(3):165-76. doi:10.1053/ctrv.2000.0210
8. Mundy GR. Mechanisms of bone metastasis. Cancer (1997) 80(8 Suppl):1546-56. doi:10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I
9. Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer (2002) 2(8):584-93. doi:10.1038/nrc867
10. Le Pape F, Vargas G, Clezardin P. The role of osteoclasts in breast cancer bone metastasis. J Bone Oncol (2016). doi:10.1016/j.jbo.2016.02.008
11. Park SI, Soki FN, McCauley LK. Roles of bone marrow cells in skeletal metastases: no longer bystanders. Cancer Microenviron (2011) 4(3):237-46. doi:10.1007/s12307-011-0081-8
12. D'Amico L, Roato I. The impact of immune system in regulating bone metastasis formation by osteotropic tumors. J Immunol Res (2015) 2015:143526. doi:10.1155/2015/143526
13. Custer CP. Studies on the structure and function of bone marrow. Part I. J Lab Clin Med (1932) 17:951-60.
14. Custer RP, Ahlfeldt FE. Studies on the structure and function of bone marrow II. J Lab Clin Med (1932) 17:960-2.
15. Scheller EL, Burr AA, MacDougald OA, Cawthorn WP. Inside out: bone marrow adipose tissue as a source of circulating adiponectin. Adipocyte (2016). doi:10.1080/21623945.2016.1149269
16. Fazeli PK, Horowitz MC, MacDougald OA, Scheller EL, Rodeheffer MS, Rosen CJ, et al. Marrow fat and bone - new perspectives. J Clin Endocrinol Metab (2013) 98(3):935-45. doi:10.1210/jc.2012-3634
17. Kawai M, Sousa KM, MacDougald OA, Rosen CJ. The many facets of PPARgamma: novel insights for the skeleton. Am J Physiol Endocrinol Metab (2010) 299(1):E3-9. doi:10.1152/ajpendo.00157.2010
18. Piney A. The anatomy of the bone marrow. BMJ (1922) 2:792-5.
19. Tavassoli M. Ultrastructural development of bone marrow adipose cell. Acta Anat (1976) 94(1):65-77. doi:10.1159/000144545
20. Tavassoli M. Marrow adipose cells. Histochemical identification of labile and stable components. Arch Pathol Lab Med (1976) 100(1):16-8.
21. Scheller EL, Rosen CJ. What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health. Ann N Y Acad Sci (2014) 1311:14-30. doi:10.1111/nyas.12327
22. Bredella MA, Fazeli PK, Miller KK, Misra M, Torriani M, Thomas BJ, et al. Increased bone marrow fat in anorexia nervosa. J Clin Endocrinol Metab (2009) 94(6):2129-36. doi:10.1210/jc.2008-2532
23. Devlin MJ, Cloutier AM, Thomas NA, Panus DA, Lotinun S, Pinz I, et al. Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J Bone Miner Res (2010) 25(9):2078-88. doi:10.1002/jbmr.82
24. Trubowitz S, Bathija A. Cell size and plamitate-1-14c turnover of rabbit marrow fat. Blood (1977) 49(4):599-605.
25. Caers J, Deleu S, Belaid Z, De Raeve H, Van Valckenborgh E, De Bruyne E, et al. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia (2007) 21(7):1580-4. doi:10.1038/sj.leu.2404658
26. Rosen CJ, Ackert-Bicknell C, Rodriguez JP, Pino AM. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. Crit Rev Eukaryot Gene Expr (2009) 19(2):109-24. doi:10.1615/CritRevEukarGeneExpr.v19.i2.20
27. Owen M. Marrow stromal stem cells. J Cell Sci Suppl (1988) 10:63-76. doi:10.1242/jcs.1988.Supplement_10.5
28. Zhang Y, Khan D, Delling J, Tobiasch E. Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. ScientificWorldJournal (2012) 2012:793823. doi:10.1100/2012/793823
29. Hasegawa T, Oizumi K, Yoshiko Y, Tanne K, Maeda N, Aubin JE. The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations. BMC Dev Biol (2008) 8:71. doi:10.1186/1471-213X-8-71
30. Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I. Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases. Cancer Metastasis Rev (2014) 33(0):527-43. doi:10.1007/s10555-013-9484-y
31. Lecka-Czernik B, Rosen CJ, Kawai M. Skeletal aging and the adipocyte program: new insights from an "old" molecule. Cell Cycle (2010) 9(18):3648-54. doi:10.4161/cc.9.18.13046
32. Gimble JM, Nuttall ME. Bone and fat: old questions, new insights. Endocrine (2004) 23(2-3):183-8. doi:10.1385/ENDO:23:2-3:183
33. Song L, Tuan RS. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J (2004) 18(9):980-2. doi:10.1096/fj.03-1100fje
34. Brümmendorf T, Rathjen F. Cell adhesion molecules 1: immunoglobulin superfamily. Protein Profile (1995) 2:963-1056.
35. Martin PJ, Haren N, Ghali O, Clabaut A, Chauveau C, Hardouin P, et al. Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs). BMC Cell Biol (2015) 16:10. doi:10.1186/s12860-015-0057-5
36. Naveiras O, Nardi V, Wenzel PL, Hauschka PV, Fahey F, Daley GQ. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature (2009) 460(7252):259-63. doi:10.1038/nature08099
37. Vainio H, Kaaks R, Bianchini F. Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev (2002) 11(Suppl 2):S94-100.
38. Slattery ML, Curtin K, Wolff RK, Herrick JS, Caan BJ, Samowitz W. Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Cancer Causes Control (2010) 21(8):1237-45. doi:10.1007/s10552-010-9551-4
39. Maccio A, Madeddu C, Gramignano G, Mulas C, Floris C, Massa D, et al. Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications. J Mol Med (Berl) (2010) 88(7):677-86. doi:10.1007/s00109-010-0611-8
40. Prieto-Hontoria PL, Perez-Matute P, Fernandez-Galilea M, Bustos M, Martinez JA, Moreno-Aliaga MJ. Role of obesity-associated dysfunctional adipose tissue in cancer: a molecular nutrition approach. Biochim Biophys Acta (2011) 1807(6):664-78. doi:10.1016/j.bbabio.2010.11.004
41. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med (2011) 17(11):1498-503. doi:10.1038/nm.2492
42. Laurent V, Guerard A, Mazerolles C, Le Gonidec S, Toulet A, Nieto L, et al. Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat Commun (2016) 7:10230. doi:10.1038/ncomms10230
43. Amemori S, Ootani A, Aoki S, Fujise T, Shimoda R, Kakimoto T, et al. Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro. Am J Physiol Gastrointest Liver Physiol (2007) 292(3):G923-9. doi:10.1152/ajpgi.00145.2006
44. Tan J, Buache E, Chenard MP, Dali-Youcef N, Rio MC. Adipocyte is a non-trivial, dynamic partner of breast cancer cells. Int J Dev Biol (2011) 55(7-9):851-9. doi:10.1387/ijdb.113365jt
45. Duong MN, Cleret A, Matera EL, Chettab K, Mathé D, Valsesia-Wittmann S, et al. Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity. Breast Cancer Res (2015) 17(1):57. doi:10.1186/s13058-015-0569-0
46. Herroon MK, Rajagurubandara E, Hardaway AL, Powell K, Turchick A, Feldmann D, et al. Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms. Oncotarget (2013) 4(11):2108-23. doi:10.18632/oncotarget.1482
47. Templeton ZS, Lie WR, Wang W, Rosenberg-Hasson Y, Alluri RV, Tamaresis JS, et al. Breast cancer cell colonization of the human bone marrow adipose tissue niche. Neoplasia (2015) 17(12):849-61. doi:10.1016/j.neo.2015.11.005
48. Gado K, Domjan G, Hegyesi H, Falus A. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma. Cell Biol Int (2000) 24(4):195-209. doi:10.1006/cbir.2000.0497
49. Jourdan M, Tarte K, Legouffe E, Brochier J, Rossi JF, Klein B. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. Eur Cytokine Netw (1999) 10(1):65-70.
50. Hideshima T, Chauhan D, Hayashi T, Podar K, Akiyama M, Gupta D, et al. The biological sequelae of stromal cell-derived factor-1alpha in multiple myeloma. Mol Cancer Ther (2002) 1(7):539-44.
51. Liu Z, Xu J, He J, Liu H, Lin P, Wan X, et al. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget (2015) 6(33):34329-41. doi:10.18632/oncotarget.6020
52. Hardaway AL, Herroon MK, Rajagurubandara E, Podgorski I. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. Clin Exp Metastasis (2015) 32(4):353-68. doi:10.1007/s10585-015-9714-5
53. Chen GL, Luo Y, Eriksson D, Meng X, Qian C, Bauerle T, et al. High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6. Oncotarget (2016) 7(18):26653-69. doi:10.18632/oncotarget.8474
54. Cawthorn WP, Scheller EL, Learman BS, Parlee SD, Simon BR, Mori H, et al. Bone marrow adipose tissue is an endocrine organ that contributes to increased circulating adiponectin during caloric restriction. Cell Metab (2014) 20(2):368-75. doi:10.1016/j.cmet.2014.06.003
55. Fowler JA, Lwin ST, Drake MT, Edwards JR, Kyle RA, Mundy GR, et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood (2011) 118(22):5872-82. doi:10.1182/blood-2011-01-330407
56. Jarde T, Caldefie-Chezet F, Goncalves-Mendes N, Mishellany F, Buechler C, Penault-Llorca F, et al. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer (2009) 16(4):1197-210. doi:10.1677/ERC-09-0043
57. Izadi V, Farabad E, Azadbakht L. Serum adiponectin level and different kinds of cancer: a review of recent evidence. ISRN Oncol (2012) 2012:982769. doi:10.5402/2012/982769
58. Dalamaga M, Karmaniolas K, Panagiotou A, Hsi A, Chamberland J, Dimas C, et al. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study. Cancer Causes Control (2009) 20(2):193-9. doi:10.1007/s10552-008-9233-7
59. Katira A, Tan PH. Evolving role of adiponectin in cancer-controversies and update. Cancer Biol Med (2016) 13(1):101-19. doi:10.28092/j.issn.2095-3941.2015.0092
60. Ye R, Scherer PE. Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab (2013) 2(3):133-41. doi:10.1016/j.molmet.2013.04.001
61. Falyank C, Fairfield H, Reagan MR. Signaling interplay between bone marrow adipose tissue and multiple myeloma cells. Front Endocrinol (2016) 7:67. doi:10.3389/fendo.2016.00067
62. Wang W, Zhao X, Wang H, Liang Y. Increased fatty acid synthase as a potential therapeutic target in multiple myeloma. J Zhejiang Univ Sci B (2008) 9(6):441-7. doi:10.1631/jzus.B0740640
63. Chajes V, Cambot M, Moreau K, Lenoir GM, Joulin V. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res (2006) 66(10):5287-94. doi:10.1158/0008-5472.CAN-05-1489
64. Zaidi N, Swinnen JV, Smans K. ATP-citrate lyase: a key player in cancer metabolism. Cancer Res (2012) 72(15):3709-14. doi:10.1158/0008-5472.CAN-11-4112
65. Lecka-Czernik B, Ackert-Bicknell C, Adamo ML, Marmolejos V, Churchill GA, Shockley KR, et al. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. Endocrinology (2007) 148(2):903-11. doi:10.1210/en.2006-1121
66. Otvos L Jr, Surmacz E. Targeting the leptin receptor: a potential new mode of treatment for breast cancer. Expert Rev Anticancer Ther (2011) 11(8):1147-50. doi:10.1586/era.11.109
67. Otvos L Jr, Haspinger E, La Russa F, Maspero F, Graziano P, Kovalszky I, et al. Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol (2011) 11:90. doi:10.1186/1472-6750-11-90
68. Weindruch R. The retardation of aging by caloric restriction: studies in rodents and primates. Toxicol Pathol (1996) 24(6):742-5. doi:10.1177/019262339602400618
69. Colman RJ, Beasley TM, Kemnitz JW, Johnson SC, Weindruch R, Anderson RM. Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat Commun (2014) 5:3557. doi:10.1038/ncomms4557
70. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis (2010) 31(1):83-9. doi:10.1093/carcin/bgp280